Proliferating eukaryotic cells possess checkpoint mechanisms that block cell division in the presence of unreplicated or damaged DNA. Using cell-free extracts from Xenopus eggs, we have investigated the mechanisms underlying the inability of a recombinant Cdc2/cyclin B complex to induce mitosis in the presence of incompletely replicated DNA. We found that the activities of the kinases and phosphatases that regulate the major phosphorylation sites on Cdc2 (e.g., tyrosine 15, threonine 14, and threonine 161) are not altered significantly under conditions where Xenopus extracts remain stably arrested in interphase due to the presence of the replication inhibitor aphidicolin. However, at threshold concentrations, a Cdc2/cyclin B complex containing a mutant Cdc2 subunit that cannot be phosphorylated on either tyrosine 15 or threonine 14 displays a markedly reduced capacity to induce mitosis in the presence of aphidicolin. This observation indicates that the replication checkpoint in Xenopus egg extracts functions without the inhibitory tyrosine and threonine phosphorylation of Cdc2. We provide evidence that the checkpoint-dependent suppression of the Cdc2/cyclin B complex involves a titratable inhibitor that is regulated by the presence of unreplicated DNA.
INTRODUCTION
In dividing eukaryotic cells, a diverse family of cyclindependent kinases (Cdks) directs the progression of the cell cycle by regulating the accurate replication of the genome during S-phase and the faithful segregation of the chromosomes at mitosis (M-phase). The M-phase of the cell cycle is controlled by maturation promoting factor (MPF), which contains a B-type cyclin and the Cdc2 protein kinase. MPF acts by phosphorylating a wide variety of substrates that collaborate in the execution of mitotic processes such as chromosome condensation, nuclear envelope breakdown, and spindle assembly (Nurse, 1990;  Solomon, 1993; reviewed in Dunphy, 1994) .
The action of MPF must be controlled both temporally and spatially in a very stringent manner. This strict regulation is imparted by a number of checkpoint mechanisms that operate during the preparation * Corresponding author.
for mitosis (reviewed in Hartwell and Weinert, 1989; Murray, 1992; Sheldrick and Carr, 1993) . A key question in the cell cycle field is how these checkpoint mechanisms control the activation and/or action of Cdks such as MPF so that cell cycle transitions occur only when all essential prerequisites have been fulfilled. In the case of M-phase, these requirements include the absence of unreplicated or damaged DNA, the attainment of an adequate cell size for division, and the accumulation of the various proteins necessary for spindle assembly and other mitotic processes.
The activation of MPF is controlled by an intricate series of phosphorylation reactions on the Cdc2 subunit (reviewed in Fleig and Gould, 1991; Draetta, 1993; Nigg, 1993; Pines, 1993; Solomon, 1993) . Specifically, phosphorylation of threonine residue 161 (T161) is absolutely required for catalytic activity, but the effect of this phosphorylation is overridden during interphase by concomitant inhibitory phosphorylations on tyrosine 15 (Y15) and threonine (T14). The tyrosine phosphorylation and subsequent dephosphorylation A. Kumagai and W.G. Dunphy of Cdc2 are mediated by the Weel and Cdc25 proteins, respectively Nurse, 1986, 1987; Dunphy and Kumagai, 1991; Gautier et al., 1991; Parker and Piwnica-Worms, 1992; McGowan and Russell, 1993) . In turn, the activities of both the Weel and Cdc25 proteins are controlled by upstream kinase/phosphatase networks, which themselves are highly regulated so that tyrosine phosphorylation of Cdc2 is strongly favored during interphase and dephosphorylation is rapidly triggered at mitosis (Solomon et al., 1990; Izumi et al., 1992; Kumagai and Dunphy, 1992; Clarke et al., 1993; Tang et al., 1993; Mueller et al., 1995) .
It has appeared highly plausible that the phosphorylation of Cdc2 on one or more of its key residues (e.g., Y15, T14, T161) would play a pivotal role in cell cycle checkpoint mechanisms. For this reason, the role of Cdc2-specific tyrosine phosphorylation in the operation of the replication checkpoint has been examined in a number of systems, including fission yeast, budding yeast, and Xenopus eggs (Enoch and Nurse, 1990; Lundgren et al., 1991; Amon et al., 1992; Enoch et al., 1992; Smythe and Newport, 1992; Sorger and Murray, 1992; Mueller et al., 1995) . However, these studies have arrived at apparently contradictory conclusions. Similarly, the roles of phosphorylation on T14 and T161 in the replication checkpoint have not been resolved conclusively.
The Xenopus egg system offers many advantages for the study of cell cycle-regulatory mechanisms. In particular, the progression of the cell cycle can be reconstituted in cytoplasmic extracts from Xenopus eggs, and the replication checkpoint can be triggered in vitro by addition of DNA synthesis inhibitors such as aphidicolin (Dasso and Newport, 1990; Murray, 1991) . Normally, activated egg extracts synthesize cyclin B, produce active MPF, and undergo mitosis in approximately 1 h (Murray and Kirschner, 1989) . However, the addition of aphidicolin results in a prolonged arrest in interphase (Dasso and Newport, 1990; Kumagai and Dunphy, 1991; Smythe and Newport, 1992; Kornbluth et al., 1992 Kornbluth et al., , 1994 . To date, the analysis of the biochemical mechanisms underlying this checkpoint has been hampered somewhat by the fact that aphidicolin-containing egg extracts arrest properly only with endogenously synthesized cyclin B. Surprisingly, recombinant, bacterially expressed cyclin B induces mitosis even in the presence of unreplicated DNA .
In this paper, we have developed an experimental system in which Xenopus egg extracts containing exogenously added, baculovirus-expressed cyclin B and Cdc2 proteins arrest properly in interphase due to the addition of aphidicolin. Accordingly, we have been able to comprehensively assess the effect of unreplicated DNA upon the phosphorylation of Cdc2 protein. The principal finding of these studies is that a Cdc2 mutant that cannot undergo phosphorylation on Y15 or T14 still responds to the replication checkpoint. We present evidence for a titratable inhibitor that interacts with the Cdc2/cyclin B complex in checkpoint-arrested extracts.
MATERIALS AND METHODS
Production of Histidine-tagged Cyclin B and ACyclin B
The human cyclin Bi cDNA (Pines and Hunter, 1989) (Desai et al., 1992; Coleman et al., 1993) . Sf9 insect cells (60 ml at a density of 2 x 106 cells/ml) were infected with the baculoviruses for 48 h, washed twice in ice-cold Tris buffered-saline (10 mM Tris-HCl, pH 7.5, 150 mM NaCl), and lysed in HBS (10 mM HEPES-KOH, pH 7.5,150 mM NaCl) containing 5 mM ethylene glycol-bis(,-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA), 0.5% Triton X-100, 1 mM phenylmethylsulfonyl fluoride, and 10 ,ug/ml each of pepstatin, chymostatin, and leupeptin. The presence of EGTA in the lysis buffer greatly reduced nonspecific binding to the nickel-IDA beads during the purification of the histidine-tagged proteins (see below). (Solomon et al., 1992) . The Cdc2-N133A mutant (containing the hemagglutinin tag) was prepared by in vitro mutagenesis using the kit from Amersham and the oligonucleotide GAAACCTCAGGCCCTCCTCATCG. The mutated cDNA was cloned into pVL1393-Cdc2 that had been digested with NcoI and PstI. Recombinant baculoviruses, prepared as described above, were used to infect Sf9 insect cells. At 48 h post-infection, the insect cells were washed twice with ice-cold Tris buffered saline and resuspended in one-tenth of the original vol of a lysis buffer that contained 10 mM HEPES-KOH (pH 7.5), 10 mM NaCl, 1 mM EGTA, 1 mM phenylmethylsulfonyl fluoride, and 10 ,ug/ml each of pepstatin, chymostatin, and leupeptin. The cells were lysed by dounce homogenization, NaCl was added to a final concentration of 150 mM, and the lysate was centrifuged at 4°C for 20 min at 10 000 rpm
Preparation of Xenopus Egg Extracts
In all cases, CSF extracts from unactivated Xenopus eggs were prepared as described previously (Murray, 1991; Kumagai and Dunphy, 1992; Tang et al., 1993) . Typically, the extracts were activated by the addition of 0.4 mM CaCl2 in the presence of 100 jig/ml cycloheximide (which prevents endogenous cyclin B synthesis). Demembranated Xenopus sperm nuclei (up to 1000 per ,ul of egg extract) were routinely added at the same time as CaCl2. Recombinant cyclin B and Acycin B proteins (20-60 nM) were added at 50 min postactivation when nuclear assembly around the sperm chromatin was complete. Depending upon their final concentration, the cyclin proteins induced mitosis in 30-60 min. The entry into mitosis was monitored by visualizing nuclear envelope disassembly and chromosome condensation by phase contrast and fluorescence microscopy Murray, 1991) . To block the extracts in interphase caused by the presence of unreplicated DNA (Dasso and Newport, 1990; Kornbluth et al., 1992) , we added 100 ,ug/ml aphidicolin (dissolved in DMSO at 10 mg/ml) to extracts containing 1000 sperm nuclei per ,ul. Control extracts lacked aphidicolin, and contained 0-1000 sperm nuclei per ,ul and 1% DMSO. In our experience, control extracts containing 0, 200, or 1000 nuclei per ,ul entered mitosis at comparable times because these extracts can carry out the efficient replication of 4000 or more nuclei per ,ul in less than 60 min. The aphidicolin-induced block to mitosis typically persisted for 120-150 min after the addition of recombinant cyclin B or Acyclin B. To overcome this block, caffeine (5 mM) or okadaic acid (3 ,M) could be added in addition to aphidicolin.
In Vitro Phosphorylation of Cdc2 on T161 ul) containing cyclin B were mixed with Sf9 insect cell lysates containing either wild-type Xenopus Cdc2 (200 ,lI vol) or the Cdc2-N133A mutant (450 ,ul vol) , and incubated at 4°C for 20 min. The beads were centrifuged, the supernatant was removed, and the beads were mixed with 50 ,lI of a fresh Cdc2-containing lysate (either wild-type or mutant). The beads were then incubated for 20 min at 22°C in the presence of 0.2 mCi 32P-ATP, 50 ,tM nonradioactive ATP, and 10 mM MgCl2 to allow the phosphorylation of Xenopus Cdc2 on T161 due to the action of a Cdkactivating kinase (CAK) present in Sf9 cell lysates. No detectable phosphorylation of T14 or Y15 occurs under these conditions. After the incubation, the beads were washed with HBS (five times) and eluted in 20 ,ul of HBS containing 200 mM imidazole.
Assay for Total Cdc2-specific Tyrosine Kinase Activity The Acyclin B protein (40 nM, final concentration) was added to cycloheximide-containing interphase extracts 50 min after activation with calcium. At various times thereafter, 100 Il aliquots were removed, chilled on ice, and then mixed with 20 ,1. of nickel-IDA agarose beads. The beads were incubated with the extract for 10 min on ice, then washed successively with HBS containing 0.1 mM sodium vanadate (once) and HBS alone (twice). Bead-associated proteins were then eluted with sodium dodecyl sulfate (SDS) gel sample buffer, electrophoresed in 10% polyacrylamide gel, and finally subjected to immunoblotting with anti-phosphotyrosine or anti-Xenopus Cdc2 antibodies. For the Cdc2-specific tyrosine kinase assays presented in this paper, we did not find it necessary to include sodium vanadate as an inhibitor of Cdc25 activity, which is low during interphase. However, similar results were obtained in the presence of sodium vanadate (our unpublished observation). Also, for the tyrosine kinase assays described in this paper, we verified that the aphidicolin-treated extracts remained arrested in interphase for the duration of the experiment.
Radiolabeling of Xenopus Cdc2 on Y15
The Cdc2/cyclin B complex (8 ,ul vol) was prepared as described above and mixed with the Xenopus Weel protein (10 ng; Mueller et al., 1995) in 40 ,lI of 50 mM Tris-HCl (pH 7.5) containing 10 mM MgCl2, 1 mM DTT, and 40 ,uCi of 32P-ATP. After a 30-min incubation at 22°C, the reaction was terminated by incubating for an additional 20 min at 37°C (which results in the thermal inactivation of the Xenopus Weel protein). The Cdc2/cyclin B complex was re-isolated with 15 ,ul of nickel-IDA beads and eluted in 40 ,ld of 200 mM imidazole in HBS.
35S-Labeling of the Xenopus Cdc2 Protein in Sf9
Insect Cells Sf9 insect cells (10 ml at 2 x 106 cells per ml) were infected with the Xenopus Cdc2-encoding baculovirus for 40 h in complete TNM-FH medium (Invitrogen, San Diego, CA). The cells were rinsed twice with methionine-free Grace's medium (Life Technologies, Inc., Gaithersburg, MD), and incubated for 7 h in 2.5 ml of the same medium containing 10% dialyzed fetal calf serum and 0.5 mCi of 35S-Translabel (ICN, Cleveland, OH). The cells were lysed and a 35S-Cdc2/cycin B complex was prepared as described above.
32P-Labeling of the Cdc2/Cyclin B Complex in

Xenopus Egg Extracts
A CSF extract (300 ,lI vol) was activated in the presence of 100 ,Lg/ml cycloheximide by the addition of 0.4 mM CaCl2 and incubated for 50 min at 22°C with 2 mCi of 32P-orthophosphate (ICN). At this time, 20 nM of cyclin B was added and the incubation was continued for 10 min. The extract was chilled on ice, mixed with nickel-IDA beads (10 ,il), incubated for 30 min at 4°C under constant agitation, and spun in a microfuge E (Beckman Instruments, Palo Alto, CA) for 5 sec. The beads were washed as follows: once with extraction buffer (80 mM sodium B3-glycerolphosphate, pH 7.3, 20 mM EGTA, and 15 mM MgCl2) containing 0.5% NP-40, 1 mM sodium vanadate, 1 ,LM microcystin, and 10 ,uM each of phosphotyrosine, phosphothreonine, and phosphoserine; five times with extraction buffer containing 0.5% NP-40; twice with HBS; and finally twice with HBS containing 25 mM imidazole. Bound proteins were eluted in HBS containing 250 mM imidazole, electrophoresed in a 10% polyacrylamide gel, and visualized with x-ray film. Bands corresponding to the Cdc2 and cyclin B proteins were processed for phosphoamino acid analysis and tryptic phosphopeptide mapping as described previously (Boyle et al., 1991 Miscellaneous HI kinase assays were performed as described previously (Dunphy and Newport, 1989) . [,y-32P]ATP (3000 Ci/mmol) for kinase assays was purchased from ICN. Affinity-purified antibodies against the bacterially expressed Xenopus Cdc2 protein (Milarski et al., 1991) were prepared by established procedures (Kumagai and Dunphy, 1992) . Antibodies against human cyclin BI and phosphotyrosine were obtained from Upstate Biotechnology (UBI, Lake Placid, NY). Immunoblotting was performed as described previously 
RESULTS
Preparation of Recombinant Cyclin B that Responds to the Replication Checkpoint in the Xenopus
System To study the mechanism by which unreplicated DNA inhibits mitosis in Xenopus egg extracts, we attempted to establish an experimental system in which an exogenously added, recombinant cyclin B or Cdc2/ cyclin B complex would be prevented from inducing M-phase in the presence of a DNA synthesis inhibitor (e.g., aphidicolin). We found that cyclin B and Cdc2 proteins that had been expressed in baculovirus-infected Sf9 insect cells were suitable for this purpose. For the studies reported in this paper, we prepared histidine-tagged versions of both the fulllength human cyclin Bi and a truncated, nondegradable mutant cyclin Bi that lacks a destruction box (Pines and Hunter, 1989; Glotzer et al., 1991) . These proteins, which we will refer to as cyclin B and Acyclin B, were purified by a modified procedure for nickel-IDA agarose chromatography that greatly reduced nonspecific binding to the nickel beads (see MATERIALS AND METHODS). Using this improved protocol, it was possible to obtain highly purified cyclin B or Acyclin B in a single step ( Figure 1A , lanes c and d). In parallel, we prepared in Sf9 cells the intact Xenopus Cdc2 protein and a variety of mutant Cdc2 proteins that lack key phosphorylatable residues, including the Cdc2-T14AY15F mutant (Cdc2-AF) in which T14 and Y15 have been mutated to alanine and phenylalanine, respectively (Solomon et al., 1992;  AND METHODS). The intact and mutant forms of Cdc2 were purified from insect cell lysates by virtue of their ability to bind to cyclin B-coated nickel agarose beads.
We prepared either the inactive or active Cdc2/ cyclin B complex for the studies described in this paper. Fortuitously, Sf9 insect cells contain an endogenous CAK that efficiently phosphorylates Xenopus Cdc2 on T161 if binding to cyclin is allowed to occur at 22°C in the presence of MgCl2 and ATP (see Desai et al., 1992) . As shown in Figure 1 , a highly purified Cdc2/cyclin B complex in which the Cdc2 subunit was phosphorylated on T161, as judged by a downward mobility shift during gel electrophoresis, was highly active as an Hi kinase ( Figure 1A , lane b; Figure 1B , lane b). Control experiments with the Cdc2-T161A mutant confirmed that this down-shifting was due to phosphorylation on T161 (our unpublished observation). In contrast, when the Cdc2/cyclin B complex was allowed to form at 4°C, it lacked T161 phosphorylation and was inactive ( Figure 1A , lane a; Figure 1B Finally, for many experiments in this paper, we prepared a complex between cyclin B and the Cdc2-AF mutant, which displayed a level of Hi kinase activity similar to the wild-type Cdc2/cyclin B complex ( Figure 1C, lanes a and b) .
Both recombinant cyclin B and Acyclin B, either alone or in a complex with Cdc2, induced mitosis efficiently, as judged by their ability to elicit both nuclear envelope breakdown and stimulation of Cdc2-associated Hi kinase activity (Figure 2 , A and C, closed circles; Figure 2B , lanes a-e). The minimal effective concentrations of cyclin B and Acyclin B for mitotic induction were 20 nM and 16 nM, respectively (see Kobayashi et al., 1991) . In contrast, neither the full-length nor the Acyclin B proteins at equivalent or considerably higher concentrations (up to 60 nM) could induce mitosis in extracts that contained the DNA synthesis inhibitor aphidicolin. In such extracts, the recombinant cyclins failed to trigger both nuclear disassembly and activation of Cdc2, typically for at least 120 min after addition to the extract (Figure 2 , A and C, closed triangles; Figure 2B , lanes f-j). As a control, we added caffeine, a drug that is known to override the inhibition of mitosis by unreplicated DNA in both tissue culture cells and Xenopus egg extracts (Schlegel and Pardee, 1987; Dasso and Newport, 1990 ). We observed that caffeine could overcome the inhibitory effect of aphidicolin ( Figure 2A , open triangles). Likewise, the addition of 3 ,uM okadaic acid could reverse the aphidicolin-induced block to mitosis (our unpublished observation).
In summary, the recombinant cyclin B and Acyclin B proteins that we prepared for this paper induce mitosis efficiently at physiological concentrations. Both cyclin proteins are stable during interphase, and the Acyclin B protein is also stable during mitosis (see Figure 2A , closed circles). As expected, the full-length cyclin B protein is degraded during mitosis (see Figure  2C , closed circles), indicating that the presence of the histidine tag does not interfere with ubiquitin-mediated proteolysis. Most importantly, neither cyclin protein can induce mitosis in the presence of unreplicated DNA, indicating that these polypeptides obey a replication checkpoint that operates in the cell cycle extracts.
Total Cdc2-specific Tyrosine Kinase Activity in Checkpoint-arrested Extracts Using both the recombinant cyclin B and Cdc2 proteins, we set out to assess the effect of unreplicated DNA upon the regulation of the enzymes that control phosphorylation at key residues on the Cdc2 protein. (Russell and Nurse, 1987; Dunphy and Newport, 1989; Gould and Nurse, 1989; Morla et al., 1989; Solomon et al., 1990; Krek and Nigg, 1991; McGowan and Russell, 1993) . To measure total Cdc2-specific tyrosine kinase activity in the Xenopus egg system, we added recombinant Acyclin B to egg extracts, isolated the resulting Cdc2/Acyclin B complex at successive intervals by chromatography on nickel-IDA agarose, and finally measured tyrosine phosphorylation of Cdc2 by immunoblotting with anti-phosphotyrosine antibodies (Figure 3, A and B) . There was A a bc d e f g hi j k a linear increase with respect to time in the phosphotyrosine content of Cdc2 as the Cdc2/cyclin B complex formed in control interphase extracts ( Figure 3A , lanes d-g; Figure 3B , open circles). However, the rate of Cdc2-specific tyrosine phosphorylation did not change in the presence of aphidicolin ( Figure 3A , lanes h-k; Figure 3B , closed circles). Moreover, the presence of caffeine in addition to aphidicolin also had no effect on Cdc2-specific tyrosine kinase activity ( Figure 3A , lanes l-o; Figure 3B , closed triangles). In contrast, the tyrosine phosphorylation of Cdc2 was greatly diminished in M-phase extracts ( Figure 3A , lanes a-c; Figure  3B , open triangles), indicating that this assay was suitable for detecting the expected reduction of total Cdc2-specific tyrosine kinase activity at mitosis (So- , 1990; Smythe and Newport, 1992; Mueller et al., 1995) .
To obtain an independent measure of Cdc2-specific tyrosine kinase activity, we also added a pre-formed Cdc2/cyclin B complex to the Xenopus extracts. In particular, we prepared a Cdc2/cyclin B complex that was specifically labeled with 32p on T161 as described in MATERIALS AND METHODS. Upon the addition of this complex to egg extracts, the labeled Cdc2 protein underwent phosphorylation on both Y15 and T14, as judged by an upward mobility shift that could be detected after gel electrophoresis ( Figure 3C) . As a control, we demonstrated that the Cdc2-AF mutant did not undergo this phosphorylation-dependent mobility shift (our unpublished observation). Using this method, we determined that neither unreplicated DNA nor caffeine affected the rate at which the labeled Cdc2 protein was converted to its tyrosine phosphorylated form ( Figure 3C , lanes d-s; note that tyrosine kinase activity is reduced in M-phase, lanes a-c). Finally, to rule out the possibility that the addition of small amounts of active Cdc2/cyclin B complex might perturb the accurate measurement of tyrosine kinase activity, we also prepared a complex of cyclin B and the kinase-negative Cdc2-N133A mutant (ConnellCrowley et al., 1993) . The Cdc2 subunit of this complex was radiolabeled with 32p on T161, and then added to interphase extracts in the absence and presence of aphidicolin ( Figure 3D ). Consistent with the results described above, there was no apparent effect of unreplicated DNA upon the rate at which this catalytically-inactive Cdc2 protein was converted to its tyrosine-phosphorylated form ( Figure 3D , compare lanes a-e with lanes f-j). In conclusion, using three different assay methods, we found that total Cdc2-specific tyrosine kinase activity was unaffected by the presence of unreplicated DNA.
Total Cdc2-specific Tyrosine Phosphatase Activity in Checkpoint-arrested Extracts Previous studies in which the C-type Cdc25 protein was immunoprecipitated from Xenopus extracts and assayed for Cdc2-specific tyrosine phosphatase activity indicated that the presence of unreplicated DNA did not affect the steady state activity of Cdc25 during interphase (Izumi et al., 1992; Kumagai and Dunphy, 1992) . However, it is conceivable that these assays did not detect other potential classes of the Cdc25 protein besides the C-type that might be important for mitotic induction (Galaktionov and Beach, 1991) . Therefore, we felt that it would be worthwhile to perform in situ measurements of total Cdc2-specific tyrosine phosphatase activity in Xenopus extracts using the baculovirus-expressed Cdc2/cyclin B complex as the substrate. For this purpose, we prepared a Cdc2/cyclin B complex that was specifically labeled with radioactive phosphate on Y15 by treatment with a Xenopus Weellike tyrosine kinase (see MATERIALS AND METH-ODS). Upon addition of this radiolabeled complex to Xenopus extracts, we observed that the 32P-phosphate on Y15 was relatively stable in interphase extracts ( Figure 4A , lanes f-t; Figure 4B ), as would be expected (Solomon et al., 1990; Izumi et al., 1992; Kumagai and Dunphy, 1992) . In contrast, the Y15 site was dephosphorylated with a rapid half-time of approximately 4 min in M-phase extracts ( Figure 4A , lanes a-e; Figure  4B , open triangles), consistent with earlier studies. However, the rate of tyrosine dephosphorylation during interphase was essentially identical in extracts that either lacked or contained aphidicolin ( Figure 4A , lanes f-o; Figure 4B ), or contained both caffeine and aphidicolin ( Figure 4A , lanes p-t; Figure 4B ). Therefore, using a recombinant Cdc2/cyclin B complex that comes under the control of a replication checkpoint in Xenopus extracts, we detected no direct modulation of total Cdc25-mediated tyrosine phosphatase activity in the presence of unreplicated DNA. During these experiments, we observed that the Cdc2 protein that was radiolabeled solely on Y15 underwent an additional phosphorylation upon incubation in the interphase extracts, which could be observed as an upward mobility shift during SDS gel electrophoresis ( Figure 4A ). Because this shift did not occur if the T14A mutant of Cdc2 was exchanged for the wild-type Cdc2 protein (our unpublished observation), we attribute this mobility shift to phosphorylation on T14. Significantly, by this assay method, we could observe no difference in the rate of T14 phosphorylation between extracts that contained aphidicolin and comparable extracts that either lacked aphidicolin or contained both caffeine and aphidicolin ( Figure 4A , lanes f-t; the top and bottom arrows denote the T14/Y15 doubly phosphorylated and Y15 singly phosphorylated forms of Cdc2, respectively). This experiment suggests that T14-specific kinase activity is not up-regulated in the presence of unreplicated DNA, at least as measured by the ability of this kinase to act upon Cdc2 that had been phosphorylated previously on Y15.
Rates of T161 Phosphorylation and Dephosphorylation in Checkpoint-arrested Extracts It is well established that phosphorylation of Cdc2 on T161 is essential for its catalytic activity. To examine the possibility that phosphorylation of T161 might be affected in the presence of unreplicated DNA, we prepared a complex between cyclin B and the 35S-labeled T14AY15F mutant of Cdc2 that can be phosphorylated only on T161 ( Figure 5 ). Upon addition of this complex to Xenopus egg extracts, the phosphorylation of the radiolabeled Cdc2 protein on T161 could be detected as a downward mobility shift during gel electrophoresis ( Figure 5A ). Because the dephosphorylation of T161 occurs very slowly in interphase extracts (Lee et al., 1994; see Figure 6 ), this assay detects the rate of T161 phosphorylation selectively. We observed that T161 phosphorylation in Xenopus extracts occurred rapidly with a half-time of approximately 1 min, but this rate did not vary depending upon the presence of unreplicated DNA or caffeine ( Figure 5A , -h) ; 1000 nuclei per ,lI of egg extract and 100 ,ug/ml aphidicolin (lanes i-m); or 1000 nuclei per ,ul, 100 ,ug/ml aphidicolin, and 5 mM caffeine (lanes n-r). At the indicated times (in minutes), aliquots were removed for electrophoresis in a 10% polyacrylamide-PDA gel. lanes f-t; Figure 5B ). Moreover, consistent with earlier reports (Solomon et al., 1992; Brown et al., 1994; Lee et al., 1994) , the rate of T161 phosphorylation was the same during both interphase and mitosis ( Figure 5A , lanes a-j; Figure 5B ).
Acting in opposition to CAK is an unknown phosphatase that dephosphorylates T161. To measure the activity of the T161-specific phosphatase, we prepared a 32P-labeled Cdc2/cyclin B complex in which Cdc2 was phosphorylated specifically on T161 as described in MATERIALS AND METHODS. Upon the addition of this substrate to interphase egg extracts, the 32P_ labeled phosphate group was quite stable whether or not the extracts contained unreplicated DNA ( Figure  6 ). Specifically, the phosphate levels on Cdc2 remained relatively constant for at least 16 min in interphase extracts that either lacked or contained aphidicolin ( Figure 6, lanes d-m) . Likewise, the presence of caffeine in addition to aphidicolin had no effect on T161 dephosphorylation (Figure 6 , lanes n-r). In contrast, there was significant dephosphorylation of T161 in an M-phase extract by the latest time point (16 min; Figure 6 , lane c), which corresponded to the time by which substantial degradation of cyclin B had occurred (our unpublished observation). Therefore, although this assay method can readily detect dephosphorylation of T161 when cyclin is degraded in mitotic extracts (Lorca et al., 1992) , the presence of unreplicated DNA has no effect upon this phosphatase activity. Collectively, these results suggest that neither phosphorylation nor dephosphorylation of T161 can account for the inability of Cdc2 to induce mitosis in the checkpoint-arrested extracts. (Figure 7 , compare panels A and B), arguing against the involvement of novel phosphorylation sites. One prediction of these findings is that a Cdc2/cyclin B complex in which the Cdc2 subunit cannot be phosphorylated on Y15 or T14 also would be unable to induce mitosis in the presence of incompletely replicated DNA. To test this possibility, we prepared a complex between Acyclin B and the Cdc2-AF protein as described above, except with the modification that the complex was purified further by gel filtration chromatography on a Superdex 200 PC column. This procedure allowed us to prepare a complex containing equimolar amounts of the Acyclin and Cdc2-AF proteins that migrated with an apparent size of 100 kDa on the gel filtration column (see silver-stained gel of a typical preparation in Figure 8A ). For these experiments, we prepared the catalytically active complex by allowing T161 phosphorylation of Cdc2 to occur before purification of the complex. In addition, we used only the Acyclin B protein in these experiments because of a poor recovery of the full-length cyclin B/Cdc2 complex from the Superdex column.
As expected, the purified Acyclin B/Cdc2-AF complex induced mitosis efficiently in cycloheximide-containing extracts that lacked aphidicolin ( Figure 8C , closed squares in panels a, b, and c). The Acyclin B/Cdc2-AF complex was very potent as a mitotic inducer: concentrations of 4 nM or greater were sufficient to trigger nuclear disassembly in the egg extracts. For comparison, it was necessary to add 16 nM of the isolated Acyclin B protein to elicit mitosis.
In parallel, we added the Acyclin/Cdc2-AF complex to aphidicolin-containing extracts. Significantly, there was a pronounced delay in the rate at which the Cdc2-AF protein could induce mitosis in these extracts relative to the control extracts, which lacked aphidicolin ( Figure 8C , closed circles in panels a, b, and c). This aphidicolin-dependent delay varied with the amount of added Acyclin/Cdc2-AF complex. At the threshold concentration that was sufficient to induce mitosis in a control extract, there was no nuclear en- velope breakdown in the aphidicolin-containing extract, even after 120 min. At an intermediate concentration of Acyclin/Cdc2-AF complex, there was only partial nuclear envelope breakdown (-30 to 40% of total) at 120 min, whereas nuclear disassembly was complete by 60 min in the control extract. Interestingly, the nuclei that did not break down in this incubation (60-70% of total) showed no indication that active Cdc2 might be present. In particular, the chromatin displayed no signs of mitotic condensation, and the nuclear envelope appeared fully intact by phase contrast microscopy (our unpublished observation). Finally, at the highest concentration of added complex in this experiment, there was still an obvious delay of approximately 20 min in the onset of mitosis in the aphidicolin-treated extract. In control experiments with 35S-labeled Cdc2-AF protein, we showed that the Cdc2-AF protein remained stably associated with Acyclin B under these conditions ( Figure 8B, lanes c and d) . Moreover, the Cdc2-AF protein in the aphidicolin-containing extract was present mainly in the T161-phosphorylated form ( Figure 8B, lane d) , as was the case in the control extract ( Figure 8B, lane c) .
To further characterize the reduced capacity of the Cdc2-AF protein to elicit mitosis in the presence of unreplicated DNA, we utilized drugs that override the replication checkpoint. We observed that the addition of caffeine could abrogate the inhibitory affect of aphidicolin upon the ability of the Cdc2-AF/Acyclin B complex to trigger nuclear envelope disassembly (Figure 9A) . Similarly, 3 ,tM okadaic acid could reverse the effect of aphidicolin upon the Cdc2-AF protein (our unpublished observation).
Next, we examined the Hi kinase activity of the Cdc2-AF/Acyclin B after re-isolation from the extracts containing unreplicated DNA. For this purpose, we added the complex to extracts in the absence and presence of aphidicolin, re-isolated the complex with nickel-IDA beads, and measured Cdc2-associated Hi kinase activity ( Figure 9B ). Under these particular conditions, the Cdc2-AF/Acyclin B complex isolated from the aphidicolin-containing extracts displayed an Hi kinase activity comparable to complexes that had been incubated either in the absence of aphidicolin or in the presence of both aphidicolin and okadaic acid ( Figure  9B , lanes d-i). One interpretation of this observation is that the Cdc2-AF/Acyclin B complex might have dissociated from an inhibitor during re-isolation of the soluble complex from the aphidicolin-containing extracts.
To evaluate this possibility, we asked whether a catalytically inert Cdc2/cyclin B complex could override the aphidicolin-dependent block to mitosis by acting as a competitor for the putative inhibitor (Figure 10 Time (min) squares); 1000 nuclei per ,ul (closed triangles, in panel b only); or 1000 nuclei per ,ul and 100 ,ug/ml aphidicolin (closed circles). At the indicated times, aliquots were removed, and nuclear envelope breakdown (NEB) was monitored by microscopy.
cles). As a control, we showed that even a twofold higher concentration of Cdc2-AFA mutant complex (20 nM) could not induce mitosis in cycloheximidecontaining extracts (closed squares), demonstrating both that the mutant Cdc2 was indeed inactive and that its bound Acyclin B partner could not activate the normal, endogenous Cdc2 protein in the extracts. These experiments suggest that a titratable inhibitor, which acts upon the Cdc2/cyclin B complex, interferes with mitotic initiation when incompletely replicated DNA is present. Further experiments have indicated that this inhibitory activity remains in the particulate fraction after isolation of the soluble Cdc2-AF/cyclin B complex (our unpublished observation), suggesting that the inhibitor might be tightly associated with the nucleus.
DISCUSSION
In these studies, we have examined the regulation of the Cdc2/cyclin B complex in Xenopus egg extracts, which cannot enter mitosis in the presence of the replication inhibitor aphidicolin (Dasso and Newport, 1990) . This drug triggers the replication checkpoint, a regulatory system of unknown nature that prevents mitosis until the replication of the genome has reached completion (Hartwell and Weinert, 1989; Dasso and Newport, 1990 In cycling Xenopus extracts, newly synthesized cyclin B normally binds to Cdc2 and triggers the phosphorylation of Cdc2 on T161, Y15, and T14 (Solomon et al., 1990) . Later, one or more Cdc25 proteins generate active MPF by dephosphorylating Y15 and T14 (Galaktionov and Beach, 1991; Kumagai and Dunphy, 1991; Sebastian et al., 1993 Nurse, 1986, 1987; Gautier et al., 1991; Kumagai and Dunphy, 1991; Mueller et al., 1995) . Moreover, there is a report that aphidicolin induces an increase of total Cdc2-specific tyrosine kinase activity in Xenopus extracts ). However, in our studies, we could not detect an aphidicolin-dependent stimulation of Cdc2-specific tyrosine kinase activity. One explanation for the discrepancy might be that the GST-sea urchin cyclin B that was utilized to form the tyrosine kinase substrate in earlier studies can override the replication checkpoint in a dominant manner (Kornbluth et al., 1992; Smythe and Newport, 1992 (Izumi et al., 1992; Kumagai and Dunphy, 1992) . Second, we could not detect an increase in T14-specific kinase activity in aphidicolin-containing extracts. Finally, the checkpoint did not appear to affect T161 phosphorylation or dephosphorylation of Cdc2, which is consistent with the fact that the Cdc2/ cyclin B complex that accumulates in aphidicolintreated extracts is fully phosphorylated on T161 (see Figure 9 ).
These paradoxical results were clarified when we observed that a Cdc2/cyclin B complex containing the Cdc2-AF mutant (which cannot be phosphorylated on Y15 or T14) displays an obvious reduction in its ability to induce mitosis in aphidicolin-containing extracts. This observation indicates that in the Xenopus system, another inhibitory mechanism that does not involve phosphorylation of Cdc2 on Y15 or T14 directs the suppression of MPF in the presence of unreplicated DNA. Obviously, it will be important to elucidate the molecular identity of this inhibitory factor and the mechanism by which unreplicated DNA controls its action.
In the yeast systems, the role of tyrosine phosphorylation in the replication checkpoint has been analyzed in a variety of genetic experiments. In the budding yeast S. cerevisiae, a strain harboring a mutant Cdc2/CDC28 protein that cannot be phosphorylated on either T18 or Y19 (the equivalents of T14 and Y15 in fission yeast and frogs) displays no defects in the replication checkpoint, and appears to grow normally in all other respects (Amon et al., 1992; Sorger and Murray, 1992; Booher et al., 1993; Stueland et al., 1993) . Moreover, Stueland et al. were able to demonstrate that the Cdc2/cyclin B complex in budding yeast arrested at the replication checkpoint was significantly smaller during gel filtration than the complex from control cells. These observations do not support the notion that the replication checkpoint in budding yeast operates exclusively through the inhibitory tyrosine and/or threonine phosphorylation of the Cdc2/CDC28 protein.
However, studies in fission yeast have suggested a different conclusion. Specifically, a fission yeast strain containing mutations in both the weel and mikl genes (whose products collaborate in the tyrosine phosphorylation of Cdc2) cannot arrest its cell cycle in the presence of the replication inhibitor hydroxyurea (Lundgren et al., 1991) . Intriguingly, single mutants in either mikl or weel display an apparently normal replication checkpoint, even though weel mutants have obvious defects in G2 size control (Enoch and Nurse, 1990; Lundgren et al., 1991; Rowley et al., 1992; Barbet and Carr, 1993) . Finally, a fission yeast strain containing a mutant Cdc2 that cannot be phosphorylated on Y15 does not undergo a mitotic delay in the presence of hydroxyurea (Gould and Nurse, 1989; Enoch et al., 1991) .
Our observations indicate that the replication checkpoint in Xenopus extracts shares common features with both the budding and fission yeast systems. On the one hand, we found that Xenopus extracts containing the Cdc2-AF mutant still undergo a pronounced mitotic delay in the presence of aphidicolin, which fits well with the observations in the budding yeast system. Conversely, the Xenopus extracts can tolerate only limited amounts of the mutant Cdc2-AF complex; at concentrations well above the threshold for mitotic initiation in control extracts, this mutant complex induces mitosis in the presence of aphidicolin, albeit with delayed kinetics (see also Norbury et al., 1991) . As a result, the extracts enter mitosis inappropriately, as is the case with fission yeast harboring the Y15F mutant of the Cdc2 protein.
A plausible interpretation of these findings is that a limiting inhibitor impedes the MPF-dependent induction of mitosis in the presence of unreplicated DNA. In parallel, one or more Weel-like kinases, which are highly active in interphase egg extracts, phosphorylate Cdc2 on Y15 and T14, resulting in the formation of a stably inactivated Cdc2/cyclin B complex. In this scenario, the Cdc2-inhibitory tyrosine and threonine kinases would not be regulated directly by the replication checkpoint. However, these kinases would play an ancillary role in helping the checkpoint function more efficiently by stably turning off the Cdc2/cyclin B complex as its concentration increases throughout interphase due to ongoing cyclin synthesis. In Xenopus extracts, this back-up system appears to be important because high concentrations of the Cdc2-AF protein can override the replication checkpoint. It is possible that a similar situation may exist in fission yeast. In fission yeast, the replication checkpoint does not operate effectively when tyrosine phosphorylation of Cdc2 cannot occur, but conversely there is no evidence that Cdc2-specific tyrosine kinase activity is modulated by the presence of unreplicated DNA (Enoch and Nurse, 1990; Lundgren et al., 1991; Rowley et al., 1992) . Finally, one might surmise that in budding yeast, the back-up system afforded by Cdc2-specific tyrosine phosphorylation is not essential.
Throughout this paper, we have addressed the problem of how unreplicated DNA leads to the initial suppression of the Cdc2/cyclin B complex. A related issue is how the inactive Cdc2/cyclin B complex that accumulates in interphase extracts containing unreplicated DNA eventually undergoes activation when replication is complete. In principle, the mechanism which impedes mitotic induction by the Cdc2-AF protein could be reversed at the end of S-phase. This event could lead to the formation of a small amount of active Cdc2, which has been hypothesized to be a trigger for the activation of Cdc25 and inactivation of Weel at mitosis (Solomon et al., 1990; Clarke et al., 1993; Izumi and Maller, 1993; Dunphy, 1994; Lee et al., Vol. 6, February 1995 
